Market Place
Sourcing Support
IMV Inc. Announces Update on CCAA Proceedings and Sales
26 Jul 2023 //
BUSINESSWIRE
IMV Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
31 Mar 2023 //
BUSINESSWIRE
IMV Inc. Announces Changes to Its Board of Directors
27 Mar 2023 //
BUSINESSWIRE
IMV Inc. Announces Fourth Quarter and Full Year 2022 Financial Results
16 Mar 2023 //
BUSINESSWIRE
Cancer biotech IMV hunts for a deal as its cash clock ticks down
16 Mar 2023 //
FIERCE BIOTECH
IMV Inc. to Announce Fourth Quarter and Fiscal Year 2022 Results
09 Mar 2023 //
BUSINESSWIRE
IMV Presents Positive Initial Results From The MVP-S Phase 2B VITALIZE Trial
13 Feb 2023 //
BUSINESSWIRE
IMV Announces Update Milestones to Advance Development of Therapeutic, MVP-S
08 Jan 2023 //
BUSINESSWIRE
IMV Announces US$9 Million Registered Direct Offering Priced At-The-Market
16 Dec 2022 //
BUSINESSWIRE
IMV Announces Data from Phase 2B VITALIZE Trial in Patients with r/r DLBCL
15 Dec 2022 //
BUSINESSWIRE
IMV Commences Trading on the TSX and Nasdaq Post-Reverse Stock Split
13 Dec 2022 //
BUSINESSWIRE
IMV Shareholders Approve Reverse Stock Split at 88%
07 Dec 2022 //
BUSINESSWIRE
IMV Provides an Update on The VITALIZE Trial
30 Sep 2022 //
BUSINESSWIRE
IMV drops 3rd of staff in refocus on lead oncology asset
16 Sep 2022 //
FIERCEBIOTECH
IMV Inc. Announces Strategic Reorganization
15 Sep 2022 //
BUSINESSWIRE
IMV Inc. to Present at Two Investor Conferences in September
01 Sep 2022 //
BUSINESSWIRE
IMV Inc. Announces Second Quarter 2022 Financial and Operational Results
11 Aug 2022 //
BUSINESSWIRE
IMV Re-Establishes At-the-Market Facility Under Renewed Base Shelf Prospectus
05 Aug 2022 //
BUSINESSWIRE
IMV to Announce Second Quarter 2022 Results on August 11, 2022
04 Aug 2022 //
BUSINESSWIRE
IMV Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
08 Jul 2022 //
BUSINESSWIRE
IMV Strengthens Its Financial Position With the $US10 Million Drawdown
22 Jun 2022 //
BUSINESSWIRE
IMV Inc. Announces First Quarter 2022 Financial and Operational Results
13 May 2022 //
BUSINESSWIRE
IMV’s Lead Compound to Be Showcased in Two Presentations at ASCO
28 Apr 2022 //
BUSINESSWIRE
IMV Presents Clinical Benefit of MVP-S + Pembrolizumab in Bladder Cancer at AACR
08 Apr 2022 //
BUSINESSWIRE
IMV Inc. to Present at Two Upcoming Investor Conferences
04 Apr 2022 //
BUSINESSWIRE
IMV Inc. says Q4 and FY 2021 Financial and Operational Results
17 Mar 2022 //
BUSINESSWIRE
IMV to Announce Q4 and Fiscal Year 2021 Results and Webcast on March 17
10 Mar 2022 //
BUSINESSWIRE
IMV to Showcase its DPX Delivery Technology in Two Presentations at AACR
09 Mar 2022 //
BUSINESSWIRE
IMV Finalizes Basket Clinical Study in Collaboration with Merck
21 Dec 2021 //
BUSINESSWIRE
IMV Inc. Announces Chief Financial Officer to Retire
22 Nov 2021 //
BUSINESSWIRE
Translational Data From the DeCidE1 Study in Patients with Advanced SITC
09 Nov 2021 //
BUSINESSWIRE
IMV’s DPX Delivery Technology to be Showcased in Two e-Posters
30 Sep 2021 //
BUSINESSWIRE
IMV Announces Final Results of the DeCidE1 Clinical Trial in Ovarian Cancer
10 Aug 2021 //
BUSINESSWIRE
IMV Announces CEO Transition
04 Aug 2021 //
BUSINESSWIRE
IMV Inc. to Announce Second Quarter 2021 Results
02 Aug 2021 //
BUSINESS WIRE
IMV to Participate in the BTIG Virtual Biotechnology Conference
29 Jul 2021 //
BUSINESSWIRE
IMV Inc. Closes Previously Announced Public Offering
20 Jul 2021 //
BUSINESSWIRE
IMV Inc. Announces Pricing of Public Offering
15 Jul 2021 //
BUSINESS WIRE
IMV Inc. files preliminary prospectus supplement in connection with proposed IPO
14 Jul 2021 //
BUSINESS WIRE
IMV Inc. files preliminary prospectus supplement in connection with proposed IPO
14 Jul 2021 //
BUSINESS WIRE
IMV Announces Annual and Special Meeting of Shareholders Voting Results
21 Jun 2021 //
BUSINESSWIRE
IMV Announces Annual and Special Meeting of Shareholders Voting Results
18 Jun 2021 //
BUSINESSWIRE
IMV Announces Appointment of Jeremy R. Graff, Ph.D. as CSO
09 Jun 2021 //
BUSINESSWIRE
IMV’s T Cell Therapy Demonstrates 86% Objective Response Rate in Combination
09 Nov 2020 //
BUSINESSINSIDER
IMV Provides Updates On COVID-19 Vaccine Program
08 Oct 2020 //
BUSINESSWIRE
IMV Announces Selection of a Vaccine Candidate Against COVID-19 Human Studies
21 May 2020 //
BUSINESSWIRE
